Development of an electronic trigger tool at a children’s hospital within an academic medical center

Author:

Fortenberry Megan1,Odinet Johlee2,Shah Pooja3,McKinzie Cameron3,Murphy Kristin3,Faircloth Cassidy Beach4,Falato Christopher3,Pappas Ashley3

Affiliation:

1. Kentucky Children’s Hospital, Lexington, KY

2. Ochsner Medical Center, New Orleans, LA

3. UNC Health Care, Chapel Hill, NC

4. Celgene, Raleigh, NC

Abstract

Abstract Purpose To evaluate the validity and reliability of select recommended triggers, defined as flags found on review of the medical record that prompt further investigation to determine the presence or absence of an adverse drug event (ADE), selected from a list initially constructed based on severity, frequency, and detectability of triggers within a pediatric population. Methods This was a single-center, retrospective cohort analysis of pediatric patients admitted to University of North Carolina (UNC) Children’s Hospital who received trigger-associated medications between January 2015 and December 2016. Patient-care areas of the emergency department, operating rooms, and post-anesthesia care units were excluded. Trigger-detection encounters were evaluated by two reviewers using pre-established, consensus ADE criteria as determined by a panel of pediatric and medication safety specialists at UNC Medical Center. Events were categorized according to medication-related trigger and analyzed using descriptive statistics. Results A total of 3,836 positive triggers were included in this study. For the aggregate 12-part trigger tool package, 1,055 positive ADEs were identified, leading to a positive predictive value (PPV) of 27.5%. A 50% increase from baseline serum creatinine, resulting from co-administration of 2 or more nephrotoxic medications accounted for a total of 3,698/3,836 (96.4%). Incomplete documentation was the leading cause for event exclusion, 8/27 (30%). The triggers with the highest PPV included protamine 4/4 (100%), flumazenil 1/1 (100%), and vancomycin-related events 51/67 (76.1%), respectively. Phenytoin level >30 µg/mL or free level >2.5 µg/mL resulted in the lowest PPV, 1/12 (8.3%). Conclusion This study lays the foundation for further studies to develop a robust pediatric trigger tool that may involve developing multi-element triggers, determining sensitivity and specificity of triggers, or mobilizing the trigger tool to an automated system. Trigger tools can be individualized to meet each institutions’ needs and unique patient population.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference17 articles.

1. The development of the Canadian paediatric trigger tool for identifying potential adverse events;Matlow;Healthc Q.,2005

2. The economics of health care quality and medical errors;Andel;J Health Care Finance.,2012

3. The incident reporting system does not detect adverse drug events: a problem for quality improvement;Cullen;Jt Comm J Qual Improv.,1995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3